Oncopharmpod

Updates: Venetoclax use in multiple myeloma, atezolizumab in small cell lung cancer

Informações:

Synopsis

This week brought several notable updates we discuss: the FDA's concern with a venetoclax clinical trial in multiple myeloma patients, atezolizumab's expected FDA-approval for small cell lung cancer, and some neuro-oncology guideline endorsements.